thomas davison Party Leader
Joined: 03 Jun 2005 Posts: 4018 Location: northumberland
|
Posted: Wed Jun 03, 2020 8:57 am Post subject: YALE EPIDEMIOLOGIST HYDROXCHLORQUINE PROMOTED IMMEDIATELY |
|
|
Yale Epidemiologist: Hydroxychloroquine Should Be �Widely Available And Promoted Immediately�
June 2, 2020 by Robert
�Every patient I�ve prescribed it (Hydroxychloroqine) to has been very, very ill and within 8 to 12 hours, they were basically symptom-free,� said Los Angeles doctor Dr. Anthony Cardillo, adding �So clinically I am seeing a resolution.�
Hydroxychloroqine � a cheap, widely-prescribed anti-malaria drug which was deemed safe for decades until it showed efficacy treating coronavirus � needs to be made �widely available and promoted immediately for physicians to prescribe,� according Yale epidemiologist Dr. Harvey Risch.
The combination of HCQ+AZ �preferably with zinc� should be �standard outpatient treatment,� Risch insists.
In a Wednesday manuscript detailing how high-risk COVID-19 patients should be treated, Risch notes that the combination of hydroxychloroquine (HCQ) and the antibiotic azithromycin (AZ) �has been widely misrepresented in both clinical reportsand public media,� and that �Five studies, including two controlled clinical trials, have demonstrated significant major outpatient treatment efficacy.�
Has already been used as standard-of-care in more than 300,000 older adults
Hydroxychloroquine+azithromycin has been used as standard-of-care in more than 300,000 older adults with multi comorbidities, with estimated proportion diagnosed with cardiac arrhythmias attributable to the medications 47/100,000 users, of which estimated mortality is <20%,9/100,000 users, compared to the 10,000 Americans now dying each week. � Dr. Harvey Risch
See entire article, including Dr. Risch�s manuscript:
https://www.zerohedge.com/health/yale-epidemiologist-hydroxychloroquine-should-be-widely-available-and-promoted-immediately |
|